Literature DB >> 20812961

Lysyl oxidase silencing impairs keratinocyte differentiation in a reconstructed-epidermis model.

Gabrielle S Le Provost1, Romain Debret, Valérie Cenizo, Géraldine Aimond, Floriane Pez, Bastien Kaniewski, Valérie André, Pascal Sommer.   

Abstract

Lysyl Oxidase (LOX) is an extracellular enzyme involved in the maturation of connective tissues. It also acts in many cell types as a regulator of cell behaviour and phenotype through intracellular signalling pathways. Recently, LOX was shown to be present in human epidermis where its precise functions remain unclear. We showed here that in confluent monolayer cultures of normal human keratinocytes (KCs) and N/TERT-1-immortalized KCs, LOX expression was induced during the first differentiation steps. Moreover, the silencing of LOX by stable RNA interference disrupted the expression of early differentiation markers. In a reconstructed-epidermis model, LOX silencing did not impair the stratification process nor the formation of the first differentiated layers. However, terminal differentiation was strongly impaired, as shown by a decreased expression of late differentiation proteins and by the absence of stratum corneum. Nonetheless, inhibition of LOX enzymatic activity by β-aminopropionitrile did not affect the differentiation process. Therefore, LOX protein acts during the first steps of KC differentiation and is important for subsequent commitment into terminal differentiation. Taken together, these results suggest that a finely regulated expression of LOX is necessary for normal KC differentiation and thus for maintenance of epidermal homeostasis.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812961     DOI: 10.1111/j.1600-0625.2010.01135.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  4 in total

1.  The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation.

Authors:  Jennie Lugassy; Shelly Zaffryar-Eilot; Sharon Soueid; Amit Mordoviz; Victoria Smith; Ofra Kessler; Gera Neufeld
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

Review 2.  Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.

Authors:  Philip C Trackman
Journal:  Expert Opin Ther Targets       Date:  2016-03-03       Impact factor: 6.902

3.  An expression screen for aged-dependent microRNAs identifies miR-30a as a key regulator of aging features in human epidermis.

Authors:  Charlotte Muther; Lara Jobeili; Maëlle Garion; Sandrine Heraud; Amélie Thepot; Odile Damour; Jérôme Lamartine
Journal:  Aging (Albany NY)       Date:  2017-11-19       Impact factor: 5.682

Review 4.  Role of the lysyl oxidase family in organ development (Review).

Authors:  Shanzun Wei; Liang Gao; Changjing Wu; Feng Qin; Jiuhong Yuan
Journal:  Exp Ther Med       Date:  2020-05-08       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.